首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Exploring the Pharmacological Mechanism of Duhuo Jisheng Decoction in Treating Osteoporosis Based on Network Pharmacology
【24h】

Exploring the Pharmacological Mechanism of Duhuo Jisheng Decoction in Treating Osteoporosis Based on Network Pharmacology

机译:基于网络药理学治疗骨质疏松症治疗骨质疏松症的药理机制

获取原文
       

摘要

Objective . The purpose of this work is to study the mechanism of action of Duhuo Jisheng Decoction (DHJSD) in the treatment of osteoporosis based on the methods of bioinformatics and network pharmacology. Methods . In this study, the active compounds of each medicinal ingredient of DHJSD and their corresponding targets were obtained from TCMSP database. Osteoporosis was treated as search query in GeneCards, MalaCards, DisGeNET, Therapeutic Target Database (TTD), Comparative Toxicogenomics Database (CTD), and OMIM databases to obtain disease-related genes. The overlapping targets of DHJSD and osteoporosis were identified, and then GO and KEGG enrichment analysis were performed. Cytoscape was employed to construct DHJSD-compounds-target genes-osteoporosis network and protein-protein interaction (PPI) network. CytoHubba was utilized to select the hub genes. The activities of binding of hub genes and key components were confirmed by molecular docking. Results . 174 active compounds and their 205 related potential targets were identified in DHJSD for the treatment of osteoporosis, including 10 hub genes (AKT1, ALB, IL6, MAPK3, VEGFA, JUN, CASP3, EGFR, MYC, and EGF). Pathway enrichment analysis of target proteins indicated that osteoclast differentiation, AGE-RAGE signaling pathway in diabetic complications, Wnt signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, calcium signaling pathway, and TNF signaling pathway were the specifically major pathways regulated by DHJSD against osteoporosis. Further verification based on molecular docking results showed that the small molecule compounds (Quercetin, Kaempferol, Beta-sitosterol, Beta-carotene, and Formononetin) contained in DHJSD generally have excellent binding affinity to the macromolecular target proteins encoded by the top 10 genes. Conclusion . This study reveals the characteristics of multi-component, multi-target, and multi-pathway of DHJSD against osteoporosis and provides novel insights for verifying the mechanism of DHJSD in the treatment of osteoporosis.
机译:客观的 。这项工作的目的是研究何井茶(DHJSD)的作用机制,治疗骨质疏松症的骨质疏松症,基于生物信息学和网络药理学的方法。方法 。在该研究中,从TCMSP数据库获得了DHJSD的每种药物成分的活性化合物及其相应的靶标。骨质疏松症被视为在突遗产,恶作剧,脱扣,治疗靶数据库(TTD),比较毒物学瘤数据库(CTD)和OMIM数据库中的搜索查询,以获得与疾病相关的基因。鉴定了DHJSD和骨质疏松症的重叠靶,然后进行了KE和KEGG浓缩分析。使用Cytoscape以构建DHJSD-化合物 - 靶基因 - 骨质疏松网络和蛋白质 - 蛋白质相互作用(PPI)网络。 CytoHubba用于选择轮毂基因。通过分子对接证实了轮毂基因和关键组分的结合活性。结果 。在DHJSD中鉴定了174个活性化合物及其205个相关潜在靶标以治疗骨质疏松症,其中包括10个枢纽基因(AKT1,ALB,IL6,MAPK3,VEGFA,Jun,Casp3,EGFR,Myc和EGF)。靶蛋白的途径富集分析表明破骨细胞分化,AGE-RAGE信号在糖尿病并发症途径,Wnt信号通路,MAPK信号传导途径,PI3K-Akt信号传导途径,JAK-STAT信号转导途径,钙信号传导途径,和TNF信号转导途径是在特异性途径由DHJSD对抗骨质疏松症。基于分子对接结果的进一步验证表明,DHJSD中含有的小分子化合物(槲皮素,kaempferolol,β-谷甾醇,β-胡萝卜素和甲基酮素)通常对前10个基因编码的大分子靶蛋白具有优异的结合亲和力。结论 。本研究揭示了多组分,多目标,和DHJSD的多途径对抗骨质疏松症的特征,并提供新的见解来检查在治疗骨质疏松症DHJSD的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号